Warning letter
Ecometics, Inc.: warning letter of Apr 16, 2019
FDA warning letter 569167 · Division of Pharmaceutical Quality Operations I
Key facts
| Reference number | 569167 |
|---|---|
| Company | Ecometics, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Apr 16, 2019 |
| Posted date | Jul 16, 2019 |
| Issuing office | Division of Pharmaceutical Quality Operations I |
| Product type | Drugs |
| CFR sections cited | 207, 211.34, 211.63, 211.67(b), 211.165(b), 211.166(a), 207.33(c) |
| Inspection city | Norwalk |
| Inspection ZIP | 06854-3706 |
| Inspection start date | Aug 17, 2018 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: